UK Eases Access To GW's Cannabidiol Epilepsy Drug
Epidyolex Also Being Rolled Out In EU Markets
The easing of the regulations governing GW Pharmaceuticals’ groundbreaking epilepsy drug in the UK will be followed by wider availability in Europe as pricing and reimbursement discussions continue.
